Further studies are required to investigate whether pharmacological TRPM2 activation may represent a new therapeutic strategy for the treatment of metabolic diseases, aimed at improving thermogenic capacity and activity of WAT and BAT. The gene discussed is TRPM2; the disease is Other metabolic disease.